To investigate the risk factors for breast cancer metastasis, we divided the patients into two groups: those with metastatic breast cancer and those with non-metastatic breast cancer. We used ultrasound-guided biopsy to obtain samples from the primary tumor site as well as from lymph nodes. These samples were then analyzed by mass spectrometry to explore the factors driving early metastasis in breast cancer.